Overview of Sulidac

Quick Facts

Property	Description
Active ingredient	Sulindac
Form	Oral tablet
Pharmacological class	Non-steroidal anti-inflammatory drug (NSAID)
Common purpose	Relief of pain, inflammation, and fever
Origin	Synthetic, indene acetic acid derivative

What is Sulidac? (Sulindac)

Defining the Drug: What Kind of Medicine is Sulindac?

Sulidac is a medicine containing the active ingredient Sulindac, a synthetic compound officially classified as a non-steroidal anti-inflammatory drug (NSAID). This medication is an indene acetic acid derivative, distinguishing its chemical structure from other NSAID subgroups. It is typically administered as an oral tablet, and as a prescription-only medication it requires professional medical guidance for its use. This classification is clinically recognized for its ability to modulate the body's inflammatory response, positioning it as a foundational agent in managing symptomatic inflammation.

Unique Nature: Why is Sulindac Classified as a Prodrug?

A critical characteristic of Sulindac is its status as a prodrug, meaning the compound itself is largely inactive upon ingestion. It requires metabolic transformation—primarily in the liver—to be converted into its active sulfide metabolite before it can exert its therapeutic effects. This unique requirement for internal processing distinguishes Sulindac from NSAIDs that are active immediately upon absorption. Pharmacological studies confirmed that Sulindac is effectively a reversible inhibitor of cyclooxygenase enzymes, linking its delayed activation to its ultimate mechanism of controlling inflammatory pathways.

General Purpose: What is the Main Benefit of Taking Sulindac?

The fundamental purpose of Sulindac is to deliver a potent anti-inflammatory effect, helping to alleviate generalized symptoms like pain, inflammation, and fever. For instance, it is typically used for patients experiencing inflammatory conditions to reduce associated swelling and discomfort. By reducing the synthesis of prostaglandins—the chemical messengers that mediate inflammation—the medicine provides systemic relief, working to control swelling and soreness associated with various inflammatory states throughout the body.

What side effects are possible with Sulidac?

Possible Side Effects and Safety Information

The official regulatory safety profile for Sulidac, a non-steroidal anti-inflammatory drug (NSAID), is structured around several mandatory warnings concerning serious and potentially fatal adverse reactions.

Serious Adverse Reactions

Regulatory documents highlight two primary, life-threatening risks that can occur at any time, often without warning:

Cardiovascular Thrombotic Events: An increased risk of serious and potentially fatal events, including heart attack (myocardial infarction) and stroke, is documented. This risk may increase with the length of treatment.
Gastrointestinal Adverse Events: There is an increased risk of serious gastrointestinal events, such as bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Elderly patients are at a greater risk for these complications.

Less common but serious organ system toxicities are also documented, including severe reactions affecting the liver (hepatotoxicity, fatal hepatitis, jaundice), kidneys (renal dysfunction, renal failure), and the blood (blood dyscrasias like aplastic anemia or agranulocytosis). Rare, serious skin reactions, such as Stevens-Johnson Syndrome, have also been reported.

Common Adverse Reactions

Frequently reported reactions include gastrointestinal disturbances such as stomach pain, nausea, diarrhea, constipation, and gas. Other common effects include headache, dizziness, nervousness, and tinnitus (ringing in the ears).

Safety-Related Restrictions

Pregnancy: The use of Sulidac is contraindicated during the third trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus. Use after 20 weeks of pregnancy may cause fetal renal dysfunction.
Surgical Use: Sulidac is contraindicated for the management of peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.
Hypersensitivity: The medicine is contraindicated in patients with a history of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs, due to the risk of severe, potentially fatal anaphylactoid reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Sulindac may present with systemic clinical manifestations, including gastrointestinal effects such as nausea, vomiting, abdominal pain, and heartburn. Central Nervous System (CNS) involvement is a key feature, commonly documented as drowsiness, confusion, agitation, severe sleepiness, and headache. Less frequently, sensory changes like blurred vision and ringing in the ears (tinnitus) may occur.

Regulatory documentation specifies the risk of severe or life-threatening outcomes, including convulsions (seizures), coma, and circulatory instability characterized by hypotension and shock. Critical organ damage, particularly kidney damage (oliguria/anuria) and chronic liver injury, has been noted in cases involving very large doses.

Emergency Action

Immediate action is required when an overdose is suspected. Emergency services must be contacted immediately if the individual shows critical signs such as collapse, trouble breathing, or inability to be awakened. The documented management approach is symptomatic and supportive, as no specific antidote is known. This typically involves activated charcoal and gastric lavage in a clinical setting, alongside continuous monitoring of vital signs and ECG to address the systemic effects. Elderly patients are recognized in labeling as being at a greater risk for serious gastrointestinal events in general.

Therapeutic Uses of Sulidac

What Sulidac Treats: Main Uses and Benefits

Sulindac is generally applied across domains where additional symptomatic support is needed for conditions marked by underlying inflammatory or irritative processes. It is commonly used to help with the symptoms related to physical discomfort, swelling, and stiffness associated with arthritis.

Supportive Relief for Chronic and Acute Inflammation

This medication is relevant in conditions characterized by periods of heightened symptoms, such as chronic disorders like Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis, and acute, disruptive episodes like Gouty Arthritis, Bursitis, and Tendinitis in the shoulder. It is used for managing symptom clusters that interfere with daily comfort, specifically persistent joint pain, stiffness, and tenderness. Sulindac may contribute to easing the overall symptom load, supporting patients during difficult episodes by easing distress.

Quick Fact: Relief for Inflammatory Discomfort

Primary Benefit Focus	Common Clinical Scenarios
Easing joint pain and swelling	Long-term control of chronic arthritis
Reducing stiffness and tenderness	Supportive relief during acute gout episodes
Supporting functional stability	Short-term relief for soft-tissue inflammation

The medication may provide supportive relief when symptoms interfere with routine activities, which may assist with maintaining functional stability and contributes to easing the overall symptom load during symptomatic periods.

Regulatory References

NIH MedlinePlus overview of Sulindac

Eligibility and Restrictions for Use

The eligibility for Sulidac is strictly defined by official regulatory documentation, primarily establishing use in adult patients (18 years and older). Use is prohibited or restricted based on clinical history, age, and organ function, as outlined by regulatory authorities.

Eligibility Scope and Restrictions

Population Status	Official Regulatory Wording
Contraindicated (Must Not Use)	Known hypersensitivity to Sulindac or NSAIDs; history of aspirin-sensitive asthma; treatment of perioperative pain in CABG surgery; Late Pregnancy (≥ 30 weeks gestation).
Use Not Established / Not Recommended	Pediatric patients (under 18 years); patients with advanced renal disease; breastfeeding mothers (due to lack of established safety data).

Official Eligibility Statements

Use requires special caution or a lower dose for older adults due to an increased risk of serious adverse gastrointestinal and renal events. Eligibility is restricted for patients with hepatic impairment and those with a history of gastrointestinal bleeding or ulcers. Patients with cardiovascular disease or risk factors are advised to use the lowest effective dose for the shortest duration to mitigate cardiovascular thrombotic risk. Safety and effectiveness have not been established in the pediatric population.

What should I know about interactions with other medicines?

The official regulatory profile for Sulindac interactions centers on combinations that result in additive toxicity risk and altered drug exposure.

Contraindicated Combinations and Key Restrictions

Sulindac is contraindicated for use in the setting of peri-operative pain associated with Coronary Artery Bypass Graft (CABG) surgery. Co-administration with Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is not recommended by manufacturers due to the documented increase in gastrointestinal adverse events and the potential for reduced plasma concentrations of Sulindac's active metabolite.

Pharmacodynamic and Pharmacokinetic Interactions

Co-administration with Anticoagulants (such as Warfarin) and Oral Corticosteroids results in pharmacodynamic reinforcement, significantly increasing the official risk of serious bleeding and hemorrhage. The medicine may also diminish the antihypertensive and diuretic effects of ACE Inhibitors, ARBs, and Diuretics (e.g., Furosemide, Thiazides). This antagonism increases the documented risk of renal function deterioration.

A key pharmacokinetic interaction is the potential for Sulindac to reduce the renal clearance of Lithium, which can lead to an elevation of plasma Lithium levels. Furthermore, official labels note that Alcohol consumption and Tobacco use are designated risk factors that compound the potential for gastrointestinal adverse events.

Population-Specific Notes

Regulatory documents note that the combination of Sulindac with RAAS-affecting drugs requires caution, particularly for elderly patients or those with compromised renal function, due to the heightened risk of renal complications.

Mechanism of Action

Enzyme-Mediated Prostaglandin Suppression

Sulindac, a prodrug, undergoes hepatic metabolism to form its active sulfide metabolite. This active species exerts its primary action by reversibly inhibiting Cyclooxygenase (COX) enzymes, targeting both COX-1 and COX-2 isoforms. COX enzymes are essential catalysts in the arachidonic acid cascade, mediating the biosynthesis of pro-inflammatory eicosanoids, primarily prostaglandins. The resultant enzymatic suppression modifies early molecular steps in the cascade, leading to a diminished production rate of these lipid signaling molecules and shaping downstream physiological responses.

Modulation of Alternative Signaling Pathways

Beyond primary COX inhibition, Sulindac and its metabolites, including the inactive sulfone, interact with other intracellular targets. These targets include specific phosphodiesterase (PDE) enzymes and key components within the NF-kappaB and Wnt/beta-catenin pathways. This engagement modulates complex signaling sequences, influencing the kinetic regulation of various cellular processes. This secondary mechanism is relevant in cellular contexts involving specific pathway modulation that contributes to regulating heightened or dysregulated cellular activity.

Dosage and Administration Information

How Sulidac is Used: Official Dosing and Administration

Sulidac (Sulindac) is strictly an oral tablet for ingestion, available in 150 mg and 200 mg strengths. All administration must adhere to the established regimen and limitations.

Official Dosing Regimens

Dosing must use the lowest effective dose for the shortest duration possible. The maximum recommended daily dose is 400 mg, and dosages above this limit are not advised.

Indication (Official)	Starting Dose (Oral)	Max Daily Dose	Typical Duration
Chronic Conditions (e.g., Arthritis)	150 mg twice daily (b.i.d.)	400 mg	Long-term use possible
Acute Conditions (Gout, Shoulder Pain)	200 mg twice daily (b.i.d.)	400 mg	7 to 14 days

Administration Requirements

Frequency: The medication is typically taken twice a day (every 12 hours).
Timing: Sulindac should be taken with food or milk (or a full glass of water) to minimize potential gastrointestinal discomfort.
Pediatric Use: The safety and effectiveness of Sulindac have not been established in children under 18 years of age.
Special Populations: Patients with significantly impaired renal function require close monitoring and a lower daily dosage to prevent drug accumulation. Similarly, a dose reduction may be required for those with hepatic impairment, as the liver is essential for drug metabolism.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Sulindac

The research surrounding Sulindac is based on studies focused on its inclusion within the non-steroidal anti-inflammatory drug (NSAID) class. The evidence base includes randomized controlled trials (RCTs), comparative studies, and systematic reviews that have been evaluated in the context of authoritative regulatory reviews.

Evidence for Symptomatic Change in Chronic Arthritis

This section summarizes the evidence base, primarily from randomized controlled trials (RCTs), concerning the compound's study for assessing symptomatic change associated with Rheumatoid Arthritis and Osteoarthritis. Research examined the compound in populations with both conditions, which are marked by functional limitations and periods of heightened symptom activity. Researchers used study designs to measure changes in outcomes related to physical discomfort, such as joint pain, tenderness, and swelling.

Research highlights changes measured during the study period, where studies monitored symptomatic patterns in the observed populations. In RA, findings describe patterns observed in the studies that included comparative agents in some trials. However, long-term outcomes related to the progression of RA or OA are not fully established, as the research focus is on short-term symptom assessment.

Research on Acute Inflammatory Episodes

Clinical studies investigated the short-term use of Sulindac for acutely symptomatic conditions like Acute Gouty Arthritis and localized inflammation (e.g., Bursitis). Research examined short-term symptom changes, with studies conducted during periods of increased symptom activity. For acute gout, studies monitored responses over defined time intervals, indicating that the most noticeable changes in pain were observed relatively quickly. For localized inflammation, symptomatic changes were generally observed within a short, defined treatment period. The evidence is limited to this acute, short-term phase, as follow-up durations were constrained in these studies.

Research Gaps and Uncertainty

The evidence structure consistently examines outcomes related to symptomatic change, but does not include studies on the long-term progression of chronic diseases like arthritis. Data for certain groups remain insufficient; for instance, few data are available for special populations such as children or for adults with the most severely functionally limited patients. Sample sizes were modest in some of the older research, and certainty remains low regarding definitive structural outcomes.

Key Studies & References

Sulindac: Trials of a new anti-inflammatory drug

Frequently Asked Questions (FAQ)

Common questions about Sulidac (FAQ)

Q: How quickly does Sulidac usually start working?

A: Information sources indicate that for chronic conditions like arthritis, it may take 1 to 2 weeks of taking the medication regularly to experience the full clinical benefit.

Q: What should I do if I forget to take a dose of Sulidac?

A: If a regular dose is missed, medication guides generally advise taking it as soon as it is remembered. However, if the time for the next scheduled dose is near, the missed dose should be skipped. Medication guides typically describe that the regular schedule should be resumed and that the dose should not be doubled.

Q: Can Sulidac be taken long-term?

A: Official documentation notes that taking this medication for a longer time may increase the risk of serious side effects. These risks include cardiovascular thrombotic events (problems related to blood clots in the heart and blood vessels) and serious gastrointestinal issues.

Q: Does Sulidac cause stomach issues?

A: Official warnings state that taking Sulidac is associated with an increased risk of serious gastrointestinal adverse events, such as stomach bleeding, ulcers, or perforations. Gastrointestinal discomforts, such as heartburn, nausea, vomiting, and stomach pain, are listed among the potential effects.

Q: Can Sulidac affect my blood pressure?

A: Regulatory warnings state that Sulidac may cause a new onset of high blood pressure or may worsen existing high blood pressure. Fluid retention has also been reported in association with its use.

Q: Is it safe to drink alcohol when on Sulidac?

A: Official drug information indicates that consuming alcohol while taking Sulidac may significantly increase the risk of serious stomach bleeding or ulceration. The combination of alcohol and Sulidac increases the risk of serious stomach bleeding or ulceration, according to official drug information.

Q: What is the risk of heart-related issues mentioned with Sulidac?

A: Sulidac carries warnings about an increased risk of serious cardiovascular thrombotic events, including heart attack and stroke, which may be fatal. This risk may increase with the length of time the medication is used.

Q: Can Sulindac affect kidney function?

A: Official regulatory warnings note that Sulindac may affect kidney function. Patients who have pre-existing kidney conditions are often advised to be closely monitored due to the potential for renal impairment.

Q: Is Sulidac the same as over-the-counter pain relievers?

A: Sulidac is classified as a nonsteroidal anti-inflammatory drug (NSAID), but unlike many common pain relievers, it is categorized as a prescription-only medication. This means it requires a valid prescription from a healthcare professional.

Q: What type of pain is Sulidac most commonly used for in studies?

A: Official indications for Sulindac include the relief of signs and symptoms associated with inflammatory conditions such as osteoarthritis, rheumatoid arthritis, acute gouty arthritis, and ankylosing spondylitis.

Q: How long does the effect of a Sulidac dose typically last?

A: Pharmacokinetic data describes the half-life of Sulindac as approximately 7.8 hours. The half-life refers to the time it takes for half of the drug to be eliminated from the body.

Q: Is it common to feel drowsy after taking Sulidac?

A: Drowsiness and dizziness are listed among the potential side effects in official medication information. If these effects occur, they should be noted.

Q: Can Sulidac interact with herbal supplements?

A: Regulatory sources generally advise patients to inform their healthcare professional about all other products they use. This includes any herbal supplements and vitamins, to allow consideration of potential interactions.

Q: Is Sulidac a narcotic or addictive medicine?

A: Sulidac is classified as a nonsteroidal anti-inflammatory drug (NSAID). It is officially designated as not a controlled substance and is not considered a narcotic.

Q: Do I need a prescription to get Sulidac?

A: Yes, Sulidac is categorized as a prescription-only medication, meaning it cannot be purchased without a valid prescription.

Q: Is it normal to see changes in my urine when taking Sulidac?

A: Changes in urination, such as a decrease in urine amount or the presence of blood or cloudiness, are listed as possible signs of unwanted effects related to kidney or liver function.

Q: Are there specific patient groups that studies on Sulidac have focused on?

A: Official documentation indicates that the medication has been studied and approved for use in specific patient populations, including those with conditions like rheumatoid arthritis, osteoarthritis, and acute painful shoulder.

Q: Can Sulidac cause allergic reactions?

A: Official warnings note that Sulidac can cause severe allergic reactions, which are also known as hypersensitivity reactions. Signs of a severe reaction, such as swelling of the face or throat, hives, or difficulty breathing, are noted as symptoms requiring medical assessment.

Q: What is the official purpose of the black box warning (if any) on Sulidac?

A: Sulidac carries Black Box Warnings to highlight the potential risk of two serious issues. These are serious and possibly fatal cardiovascular thrombotic events (heart attack and stroke) and serious gastrointestinal adverse events (bleeding, ulceration, and perforation).

Q: Can Sulidac cause liver problems?

A: Regulatory sources report that Sulidac may impact liver function, including increases in liver enzyme levels. Although rare, severe liver injury has also been reported.

Q: Does Sulidac contain aspirin?

A: Sulindac is classified as a non-aspirin nonsteroidal anti-inflammatory drug (NSAID). It does not contain aspirin and is generally not recommended for use in combination with aspirin.

Q: What is the active ingredient in Sulidac?

A: The active ingredient in Sulidac is Sulindac.

Q: Is Sulidac used to treat arthritis?

A: Yes, official indications for this medication include the relief of signs and symptoms associated with osteoarthritis and rheumatoid arthritis.

Q: Are there common signs that Sulidac is not agreeing with me?

A: Information sources list common and severe side effects that serve as warning signs. Examples include black or bloody stools, chest pain, swelling of the face or throat, or yellowing of the skin or eyes.

Q: What is the typical age range for people taking Sulidac?

A: The safety and effectiveness of Sulindac have not been established for use in children under 18 years of age. Official documents also note that special precautions are advised for elderly patients due to their potential sensitivity to the medication’s effects.

Q: Are there different forms of Sulidac (e.g., tablet, liquid)?

A: Official dosage forms listed in regulatory documents indicate that Sulidac is available as an oral tablet.

Q: Where can I find the official regulatory information about Sulidac?

A: Official drug labels, package inserts, and regulatory information can typically be found through government-run resources. These include databases from the FDA (Food and Drug Administration) and the NIH/MedlinePlus.

Q: Is Sulidac only for pain, or does it treat other symptoms?

A: As a nonsteroidal anti-inflammatory drug (NSAID), Sulindac is used to relieve both pain and signs and symptoms of inflammation associated with its approved indications.

Q: Is it true that Sulidac can interact with lithium?

A: Official drug information describes an interaction where Sulindac may reduce the body's ability to clear Lithium through the kidneys. This could potentially lead to an elevation of plasma Lithium levels.

Q: Does Sulidac cause sensitivity to the sun?

A: Official patient information states that Sulidac may increase sensitivity to the sun (photosensitivity).

Q: Why is Sulidac sometimes taken with food?

A: Official guidance indicates that Sulidac may be taken with food, milk, or an antacid. This is done to help minimize potential gastrointestinal discomfort that the medication can cause.

How should Sulidac be stored and disposed of?

How to Store and Dispose of Sulindac

Official regulatory documents define mandatory conditions for the storage and final disposal of Sulindac tablets.

Storage Requirements

Sulindac must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medicine must be kept from freezing and protected from excess heat, moisture, and direct light. To maintain stability, the tablets must be stored in the original container and kept tightly closed. For safety, the medication must always be stored out of the reach of children.

Disposal Instructions

Outdated or unused Sulindac must be properly discarded. The labeled instruction is to ask a healthcare professional or pharmacist for guidance on disposal. Medications should not be disposed of in wastewater (such as flushing down the toilet).

Sulidac